Does Trandolapril Tablets Interact with Potassium Supplements?
CDI records a moderate classification for Trandolapril Tablets and Potassium Supplements. The stored summary is: Concomitant use with ACE inhibitors increases risk of hyperkalemia. Use with caution and appropriate monitoring of serum potassium. The mechanism involves increased serum potassium. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Trandolapril Tablets Class
- Angiotensin Converting Enzyme Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Increased serum potassium
What To Tell Your Doctor or Pharmacist
If you are taking Trandolapril Tablets and your doctor is considering prescribing Potassium Supplements (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider